Weight Loss Intervention With Lean Muscle Mass Retention
WLMR
1 other identifier
interventional
100
1 country
1
Brief Summary
Overweight and obesity (i.e., excess body fat) is a worldwide health problem, which predisposes individuals to various metabolic diseases. Weight loss through lifestyle modifications such as dietary calorie restrictions and/or exercise are effective approaches to reduce excess body fat. However, lean muscle mass loss is often an undesired outcome associated with weight loss, which should be avoided, particularly in older adults, who are also faced with declining anabolic responses to dietary protein intake. Given the increased interest and popularity of plant-based diets, in this study we will compare two distinct calorie-restricted, weight loss diets, both supplemented with weekly exercise, predominantly consisting of either plant-based proteins or animal-based proteins on changes in total body weight, body fat and lean muscle mass, as well as associated changes in metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2022
CompletedFirst Submitted
Initial submission to the registry
September 22, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedNovember 7, 2022
November 1, 2022
5 months
September 22, 2022
November 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Body Mass
kg
16 weeks (from first to final measurement visits)
Body Fat %
16 weeks (from first to final measurement visits)
Muscle Mass
kg
16 weeks (from first to final measurement visits)
Secondary Outcomes (12)
HbA1c
16 weeks (from first to final measurement visits), measured every 8 weeks
Fasting glucose
16 weeks (from first to final measurement visits), measured every 4 weeks
Fasting insulin
16 weeks (from first to final measurement visits), measured every 4 weeks
Oral glucose tolerance test
16 weeks (from first to final measurement visits), measured every 8 weeks
Blood lipid profile (HDL, LDL, Total Cholesterol, Triglyceride)
16 weeks (from first to final measurement visits), measured every 4 weeks
- +7 more secondary outcomes
Study Arms (2)
Low-Calorie Control Group
ACTIVE COMPARATORThe control group will receive 2x calorie-restricted balanced meals per day, each consisting of a portion of animal proteins (\~20g), a portion of vegetables, and a portion of starch (rice/ noodles) per meal. The group will also receive a mid-morning beverage in the form of a malted drink (\~150 kcal and \~5g protein). The third meal of the day and any additional snacks will be left to the free choice of the participants, with calorie advice provided by study dietitian. Calorie restriction aims to reduce body weight of individual participants by \~5 - 10%. The group will also be asked to undergo a supervised mixed exercise regime three days per week, 1 hour per day. The mixed exercise regime will consist of 2 sessions of resistance training and 1 session of aerobic training.
Low-Calorie Treatment Group
ACTIVE COMPARATORThe treatment group will receive 2x calorie-restricted balanced meals per day, each consisting of a portion of plant proteins (\~25g), a portion of vegetables, and a portion of starch (rice/noodles) per meal. The group will also receive a mid-morning beverage, in the form of a soy-based, plant protein beverage (\~120 kcal and 13g protein). The third meal of the day and any additional snacks will be left to the free choice of the participants, with calorie advice provided by study dietitian. Calorie restriction aims to reduce body weight of participants by \~5 - 10%. The group will also be asked to undergo a supervised mixed exercise regime three days per week, 1 hour per day. The mixed exercise regime will consist of 2 sessions of resistance training and 1 session of aerobic training.
Interventions
Consume reduced calorie ready meals with animal proteins to substitute participants' two main meals/day plus a serving of malted beverage to be consumed every day for a period of 16 weeks. Additional supervised exercise regime made up of 2 hours of resistance training plus 1 hour of aerobic training per week for a period of 16 weeks.
Consume reduced calorie ready meals with plant proteins to substitute participants' two main meals/day plus a serving of soy-based plant protein beverage to be consumed every day for a period of 16 weeks. Additional supervised exercise regime made up of 2 hours of resistance training plus 1 hour of aerobic training per week for a period of 16 weeks.
Eligibility Criteria
You may qualify if:
- Male or Female
- Chinese ethnicity
- Age between 40 to 69 years
- Able to give informed consent
- Body Mass Index (BMI) between 23.0 to 32.5 kg/m2
You may not qualify if:
- Smoking
- Having allergies or intolerances to any common food ingredients including eggs, fish, milk, peanuts, and tree nuts, shellfish, soya, wheat, gluten, cereal, fruits, dairy products, meat, vegetable, sugar and sweetener, natural food colourings or flavourings, etc
- Following special diets or having intentional dietary restrictions (e.g, vegetarians/vegans)
- Not willing to stop consumption of probiotic or prebiotic supplements within 4 weeks prior to start of study if currently taking these, as well as during study participation
- Not willing to adhere to diet modification as in the study protocol
- Not willing to adhere to the exercise regime as in the study protocol
- Taking part in strenuous physical activities
- Not willing to stop any strenuous activity during or within 24 hours of test days (for those actively participating in sports at the competitive and/or endurance levels)
- Having glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
- Having alcohol consumption on \> 4 days per week with ≥ 6 alcoholic drinks per week
- Having sustained elevation of blood pressure (\>160/95 mm Hg)
- Having previously undergone any gastrointestinal surgery or having history of gastrointestinal disorders
- Having a history of heart, liver, kidney, blood disorders (e.g., thalassemia) or thyroid dysfunctions
- Diabetic
- Having history of tuberculosis, HIV, Hepatitis B or Hepatitis C infections
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Nutrition Research Centre
Singapore, 117599, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 22, 2022
First Posted
November 7, 2022
Study Start
July 18, 2022
Primary Completion
December 15, 2022
Study Completion
December 15, 2022
Last Updated
November 7, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share